Publicatie datum


de Oliveira Bressane Lima, P., Verberk, J.D.M., Suijkerbuijk, A.W.M., Pijnacker, R., Veldhuijzen, I.K., Mollers, M., Dongen, J.A.P. van, Vennema, H., Hooiveld, M., Bruijning-Verhagen, P., Melker, H.E. de. Rotavirus. In: Schurink-van 't Klooster and H.E. de Melker (Eds.)The National Immunisation Programme in the Netherlands: Surveillance and developments in 2018-2019. RIVM, Bilthoven p. 212-218.
Download de PDF
Key points
- The rotavirus season in 2018 was comparable to that in 2017, contradicting the previous hypothesis of a biennial pattern that was formulated due to low-endemic rotavirus seasons in 2014 and 2016. Until mid-July 2019, fewer rotavirus cases have been observed compared to the same period in 2018.
- In July 2018, the Ministry of Health, Welfare and Sport decided to offer vaccination to infants belonging to risk groups. The process of implementation is ongoing.
- G9P8 and G3P8 were the most prevalent genotypes in 2018.
- A thermostable vaccine (ROTASIIL) has achieved WHO prequalification. Four rotavirus vaccines are currently available worldwide, of which two (Rotarix and RotaTeq) are licensed for use in Europe.